by Aucentra Admin | Jun 28, 2022 | Aucentra News
ADELAIDE, Australia- 12 May 22 On 12th May 2022, Professor Shudong Wang, invited by the University of South Australia Dean of Research Clinical Health & Sciences, held a live webinar to discuss her ground-breaking pancreatic cancer research drug discovery and...
by Aucentra Admin | Mar 28, 2022 | Aucentra News
ADELAIDE, Australia – 25/03/2022 Aucentra Therapeutics (https://www.aucentra.com/) is pleased to announce the appointment of Mr. Joe Bayer as Chief Executive Officer to lead the company in its growth and commercial phase. Aucentra Therapeutics is a clinical stage...
by Aucentra Admin | Feb 25, 2022 | Aucentra News
24 February 2022 Adelaide, Australia- Aucentra Therapeutics is pleased to announce that it has received regulatory approval to progress to a Phase 1a/b clinical trial of Auceliciclib (AU3-14) in combination with Temozolomide for recurrent/refractory GBM patients....
by Aucentra Admin | Jan 25, 2022 | Aucentra News
Aucentra is thrilled to announce the appointment of John de Groot, MD, to our Scientific Advisory Board. Dr de Groot specializes in the treatment of patients with brain tumors, including glioblastomas and other gliomas. He is recognized for his expertise in...
by Aucentra Admin | Jan 25, 2022 | Aucentra News
Aucentra Therapeutics is delighted to announce the appointment of Professor Chris Pepper to our Scientific Advisory Board. Prof Chris Pepper is the Chair in Cancer Research at the Brighton and Sussex Medical School, UK. His research career has been extensive and...
Recent Comments